Dr. Agarwal's Eye Hospital Limited Stock

Equities

DRAGARWQ6

INE934C01018

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:23:02 2024-05-21 am EDT 5-day change 1st Jan Change
3,162 INR -4.11% Intraday chart for Dr. Agarwal's Eye Hospital Limited -9.24% +13.26%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 2.01B 24.2M Sales 2023 2.68B 32.18M Capitalization 4.3B 51.68M
Net income 2022 241M 2.9M Net income 2023 369M 4.43M EV / Sales 2022 2.53 x
Net Debt 2022 1.65B 19.87M Net Debt 2023 2.05B 24.64M EV / Sales 2023 2.37 x
P/E ratio 2022
14.3 x
P/E ratio 2023
11.7 x
Employees 974
Yield 2022
0.41%
Yield 2023
0.33%
Free-Float 23.66%
More Fundamentals * Assessed data
Dynamic Chart
Dr. Agarwal's Eye Hospital Opens New Branch in Tamil Nadu, India MT
Dr. Agarwal's Eye Hospital's Consolidated Net Profit Drops in Fiscal Q4 MT
Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Financial Year 2023-2024 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Dr. Agarwal's Eye Hospital Opens New Branch in Puducherry, India MT
Dr. Agarwal's Eye Hospital Opens Two New Branches in Tamil Nadu, India MT
Dr. Agarwal's Eye Hospital Begins Operations of New Branch in Pudukkottai, India MT
Dr. Agarwal's Eye Hospital Begins Operations of Tirurvannamali Branch MT
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Dr. Agarwal's Eye Hospital Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before 18 November 2023 CI
Dr. Agarwal's Eye Hospital Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2023 CI
Indian Equities End Lower, Weighed Down by Potential Rate Hikes in US, Worsening Chinese Economy MT
Dr. Agarwal Gets $80 Million from TPG Growth, Temasek MT
More news
1 day-4.11%
1 week-9.24%
Current month-10.35%
1 month-3.64%
3 months-7.22%
6 months+13.09%
Current year+13.26%
More quotes
1 week
3 100.00
Extreme 3100
3 589.00
1 month
3 100.00
Extreme 3100
3 660.00
Current year
2 541.80
Extreme 2541.8
3 660.00
1 year
1 350.00
Extreme 1350
3 660.00
3 years
375.00
Extreme 375
3 660.00
5 years
169.20
Extreme 169.2
3 660.00
10 years
66.50
Extreme 66.5
3 660.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 19-06-02
Founder 63 94-04-21
Director of Finance/CFO - 20-12-06
Members of the board TitleAgeSince
Director/Board Member 59 22-06-22
Founder 63 94-04-21
Chief Operating Officer 39 09-05-18
More insiders
Date Price Change Volume
24-05-21 3,162 -4.11% 2 766
24-05-18 3,298 -1.72% 462
24-05-17 3,356 -3.33% 1,493
24-05-16 3,472 +0.53% 1,207
24-05-15 3,453 -1.17% 444

Delayed Quote Bombay S.E., May 21, 2024 at 06:23 am EDT

More quotes
Dr. Agarwal's Eye Hospital Limited an India-based company, which is primarily engaged in providing eye care and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Puducherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.
More about the company
  1. Stock Market
  2. Equities
  3. DRAGARWQ6 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW